GADD45B and neoplasm: These results demonstrated that alteration of GADD45B was related to environment stresses and clinical treatment, suggesting that low expression of GADD45B may promote the tolerance of mPCa to harsh microenvironments and chemotherapy, which in turn leads to tumor progression.